Man Group’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$332K Buy
+63,351
New +$215K ﹤0.01% 2154
2025
Q3
Sell
-43,475
Closed -$121K 2251
2025
Q2
$121K Buy
43,475
+14,602
+51% +$48K ﹤0.01% 2112
2025
Q1
$104K Buy
+28,873
New +$116K ﹤0.01% 2109
2024
Q1
Sell
-30,872
Closed -$29.4K 2134
2023
Q4
$29.4K Buy
+30,872
New +$30.3K ﹤0.01% 2015
2023
Q3
Hold
0
1858
2023
Q1
Sell
-16,171
Closed -$15K 2100
2022
Q4
$15K Sell
16,171
-303,923
-95% -$406K ﹤0.01% 1977
2022
Q3
$544K Buy
+320,094
New +$838K ﹤0.01% 1489
2022
Q2
Sell
-149,416
Closed -$397K 1570
2022
Q1
$530K Sell
149,416
-14,499
-9% -$42K ﹤0.01% 1565
2021
Q4
$610K Buy
+163,915
New +$1.01M ﹤0.01% 1475

Other funds holding CLOV

Man Group's CLOV Position: Q2 2026 in Review

Man Group opened a new position in Clover Health Investments (CLOV) in Q2 2026: 63,351 shares worth $332K. The stake represents ﹤0.01% of the portfolio and ranks #2154 among its holdings. This is a return to the name: Man Group previously reported a position in CLOV as recently as Q2 2025.

Man Group first reported a position in CLOV in Q4 2021 and has held it in 8 quarters since. The position peaked at $610K in Q4 2021. 226 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Man Group held 63,351 shares of Clover Health Investments worth $332K as of Q2 2026.
  • Clover Health Investments was a new Man Group position in Q2 2026.
  • Clover Health Investments made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #2154 holding.
  • Man Group first reported a position in Clover Health Investments in Q4 2021 and has held it in 8 quarters since.
  • Man Group's Clover Health Investments position peaked at $610K in Q4 2021.
  • 226 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.